2015
Afamelanotide for erythropoietic protoporphyria
Publication
Publication
New England Journal of Medicine , Volume 373 - Issue 1 p. 48- 59
Copyright
| Additional Metadata | |
|---|---|
| doi.org/10.1056/NEJMoa1411481, hdl.handle.net/1765/81522 | |
| New England Journal of Medicine | |
| Organisation | Department of Internal Medicine |
|
Langendonk, J., Balwani, M., Anderson, K., Bonkovsky, H. L., Anstey, A. V., Bissell, D. M., Bloomer, J., Edwards, C., Neumann, N. J., Parker, C., Phillips, J. D., Lim, H. W., Hamzavi, I., Deybach, J.-C., Kauppinen, R., Rhodes, L. E., Frank, J., Murphy, G. M., Karstens, F., … Desnick, R. (2015). Afamelanotide for erythropoietic protoporphyria. New England Journal of Medicine, 373(1), 48–59.https://doi.org/10.1056/NEJMoa1411481 |
|